STERIS plc (Ireland)
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Daniel A. Carestio
- Full Time Employees
- 17,937
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 5960 Heisley Road Dublin OH Ireland 44060
- IPO Date
- Nov 3, 2015
- CIK
- 0001757898
- Website
- steris.com
- Similar Companies
- Business
- STERIS plc (NYSE: STE), headquartered in Dublin, Ireland, with U.S. operational headquarters in Mentor, Ohio, is a leading global provider of infection prevention, contamination control, and procedural support products and services to healthcare, pharmaceutical, medical device, life sciences, and industrial customers in more than 100 countries. Founded in 1985 as Innovative Medical Technologies, the company offers capital equipment including steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, automated washer/disinfectors, surgical tables, lights, booms, operating room integration systems, and automated endoscope reprocessors; consumables such as detergents, disinfectants, endoscopy accessories, barrier products, sterility assurance indicators, biological and chemical monitoring tools, sterilization pouches, and surgical instruments including V. Mueller, Snowden-Pencer, and Genesis brands; and services encompassing equipment installation and maintenance, instrument and scope repair, outsourced reprocessing, laboratory testing, contract sterilization via gamma irradiation, electron beam, ethylene oxide, and X-ray technologies, and gastrointestinal support solutions. STERIS operates through segments including Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies, targeting hospitals, surgery centers, medical device and pharmaceutical manufacturers, research facilities, and bioprocessing clients with a workforce exceeding 18,000 associates. Recent developments include the 2023 acquisition of Becton, Dickinson and Company's surgical instrumentation, laparoscopic, and sterilization container assets to expand healthcare offerings; facility expansions such as the 2025 openings of an ethylene oxide processing plant in Batu Kawan, Malaysia, and an X-ray processing addition in Suzhou, China; a 2024 business segment restructuring; and fiscal 2025 guidance projecting 8-9% revenue growth driven by consumables, services, and bioprocessing demand.
Company News
STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026
Reasons to Add STE Stock to Your Portfolio Right Now
STERIS plc $STE Shares Bought by Perpetual Ltd
Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
Steris to Acquire Xodus Medical for $2.1 Billion
Rep. Kevin Hern Unloads Shares of Honeywell International Inc. (NASDAQ:HON)
Crane (NYSE:CR) Stock Sold Off by Rep. Kevin Hern
Colgate-Palmolive (NYSE:CL) Stock Sale Revealed by Rep. Kevin Hern
Walmart (NASDAQ:WMT) Shares Unloaded by Rep. Kevin Hern
Novo Nordisk A/S (NYSE:NVO) Stock Sold Off by Rep. Kevin Hern
Rep. Kevin Hern Sells Shares of Devon Energy Corporation (NYSE:DVN)
Danaher (NYSE:DHR) Stock Unloaded by Rep. Kevin Hern
Rep. Kevin Hern Sells Shares of ONEOK, Inc. (NYSE:OKE)
Pembina Pipeline (NYSE:PBA) Stock Sold by Rep. Kevin Hern
Rep. Kevin Hern Purchases Shares of CocaCola Company (The) (NYSE:KO)
Novartis (NYSE:NVS) Stock Sold by Rep. Kevin Hern
CSX (NASDAQ:CSX) Shares Sold by Rep. Kevin Hern
Progress Software (NASDAQ:PRGS) Stock Sold Off by Rep. Kevin Hern
PTC (NASDAQ:PTC) Stock Sale Disclosed by Rep. Kevin Hern